Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Verastem (VSTM) Gains from Investment Securities (2018 - 2025)

Historic Gains from Investment Securities for Verastem (VSTM) over the last 8 years, with Q3 2025 value amounting to $55.9 million.

  • Verastem's Gains from Investment Securities rose 51525.6% to $55.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $70.6 million, marking a year-over-year increase of 62634.6%. This contributed to the annual value of $19.1 million for FY2024, which is N/A changed from last year.
  • Verastem's Gains from Investment Securities amounted to $55.9 million in Q3 2025, which was up 51525.6% from -$20.3 million recorded in Q2 2025.
  • Verastem's 5-year Gains from Investment Securities high stood at $55.9 million for Q3 2025, and its period low was -$20.3 million during Q2 2025.
  • Moreover, its 5-year median value for Gains from Investment Securities was $2.1 million (2023), whereas its average is $7.6 million.
  • In the last 5 years, Verastem's Gains from Investment Securities skyrocketed by 11691050.0% in 2022 and then tumbled by 101538.42% in 2025.
  • Over the past 5 years, Verastem's Gains from Investment Securities (Quarter) stood at -$1000.0 in 2021, then skyrocketed by 116910.5% to $1.2 million in 2022, then surged by 81.54% to $2.1 million in 2023, then surged by 1437.62% to $32.6 million in 2024, then surged by 71.38% to $55.9 million in 2025.
  • Its Gains from Investment Securities stands at $55.9 million for Q3 2025, versus -$20.3 million for Q2 2025 and $2.4 million for Q1 2025.